AI Innovations in COVID-19 Treatment

This chapter explores how artificial intelligence is transforming drug development in response to the COVID-19 pandemic, with a focus on companies like Deerjen and InSilico Medicine. It discusses the potential of AI in predicting drug interactions and generating new molecules, as well as the ethical implications of AI in medical decision-making. The chapter highlights the urgency for diverse treatment options and the application of AI technologies in public health measures.